Answers are grounded in this paper and cite their sources.
BACKGROUND: Current therapies used in symptomatic knee osteoarthritis (OA) are effective in relieving symptoms but cannot modify the disease. Recently, a novel one-step, enzyme-free SVF adipose tissue-enrichment system (Hy-tissue SVF) has been placed into the market. The aim of this retrospective study is to assess if a single injection of adipose tissue enriched in stromal vascular fraction (at-SVF) via this one-step enzyme free protocol, is effective and safe in managing knee OA symptoms.METHODS: Twenty-five patients, aged 40-85 years and with a diagnosis of knee OA Kellgren-Lawrence grade II-III, have been treated with a single intra-articular at-SVF dose (8-10 ml) and followed up for 1, 3 and 6 months. Treatment efficacy has been measured using the Western Ontario and Mc Master University (WOMAC) questionnaire.RESULTS: The evaluation of pain, stiffness and physical function demonstrated a significant improvement in the short-term that persisted until the end of the follow-up visit at 6 months. The WOMAC total score suggested the same trend of improvement during the whole period of observation.CONCLUSIONS: A single intra-articular injection of autologous at-SVF is successful in relieving pain and improving both knee stiffness and physical function in a well-tolerated and safe manner. The effects of a single intra-articular injection of at-SVF are appreciable in the short-term but also, most important, in the medium-term thus possibly enhancing the quality of life of the patients.
No takes yet. Share an insight, caveat, or question.
PRIANO et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: